Standard Glass Lining Technology, a company that specializes in designing and manufacturing equipment for pharmaceutical and chemical manufacturers, recently saw a successful IPO listing. The stock closed 16.68 per cent higher on its first day of trading, reaching ₹163.35 on the BSE. This was a significant increase from its IPO price of ₹140, despite facing heavy selling pressure in the secondary market.
The IPO received an overwhelming response from investors, with bids coming in at 182.57 times the number of shares on offer. Qualified institutional buyers bid 331.60 times, non-institutional investors bid 267.99 times, and retail investors bid 63.99 times. The ₹410.05-crore IPO received bids for 380.27 crore shares against 2.08 crore shares on offer.
Prior to the IPO, the company raised ₹123 crore from anchor investors, including both domestic and foreign institutions. Some of the key investors included Amansa Holdings Private Ltd, ICICI Prudential MF, Tata MF, and Kotak Mahindra Trustee Co Ltd.
The company plans to utilize the funds raised from the IPO for capital expenditure, repayment of outstanding borrowings, and investment in its subsidiary, S2 Engineering Industry Private Ltd. Standard Glass Lining Technology offers a wide range of solutions for pharmaceutical and chemical manufacturers, including reaction systems, storage, separation, and drying systems.
Overall, the successful IPO listing and strong investor response indicate confidence in the company’s growth prospects and the demand for its products and services in the pharmaceutical and chemical industries. Investors will be closely watching how Standard Glass Lining Technology utilizes the funds raised to drive further expansion and innovation in its operations.
